Skip to main content

Table 4 Healthcare expenditure of high-cost and non-high cost MASLD individuals in 2019 (€)

From: Factors associated with high costs of patients with metabolic dysfunction-associated steatotic liver disease: an observational study using the French CONSTANCES cohort

Mean (standard deviation)

Total N = 14,437

High cost 1444 (10%)

Non-high cost 12,993 (90%)

General practitioner consultations

104 (106)

214 (166)

92 (89)

Consultations with other professionals

285 (583)

1209 (1391)

183 (239)

Practice nurse consultations

20 (175)

141 (529)

7 (32)

Other paramedical care

86 (261)

330 (603)

59 (166)

Dental care

74 (137)

100 (188)

74 (137)

Laboratory tests

71 (153)

269 (380)

49 (72)

Medical devices

144 (591)

824 (1634)

68 (186)

Audio prostheses

4 (37)

5 (44)

3 (37)

Drugs

397 (1713)

2261 (4963)

190 (308)

Transportation

37 (367)

305 (1046)

7 (138)

Hospital care

673 (3244)

5509 (8825)

136 (391)

Total healthcare cost

1860 (4634)

10,863 (10,859)

859 (866)